Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06841042
What this trial is testing

SCTB35 in Patients with Systemic Lupus Erythematosus

Who this might be right for
System Lupus Erythematosus
Sinocelltech Ltd. 168
Not applicableStudy completedNCT05287581
What this trial is testing

Motivating Individuals With Lupus to Exercise

Who this might be right for
Systemic Lupus Erythematosus
University of Michigan 32
Post-approval studies (Phase 4)Study completedNCT00668330
What this trial is testing

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Chinese University of Hong Kong 40
Not applicableStudy completedNCT00010400
What this trial is testing

Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Antibody Syndrome
Johns Hopkins University 35
Early research (Phase 1)Looking for participantsNCT07432334
What this trial is testing

CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Vinmec Research Institute of Stem Cell and Gene Technology 8
Early research (Phase 1)Looking for participantsNCT06576271
What this trial is testing

GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 142
Large-scale testing (Phase 3)Active Not RecruitingNCT04895241
What this trial is testing

Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Biogen 548
Post-approval studies (Phase 4)Study completedNCT01632241
What this trial is testing

Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 503
Not applicableStudy completedNCT01772069
What this trial is testing

Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus:Focusing on Fibromyalgia

Who this might be right for
Quality of Life
The Catholic University of Korea 300
Large-scale testing (Phase 3)Looking for participantsNCT04702256
What this trial is testing

Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 196
Post-approval studies (Phase 4)WithdrawnNCT02779153
What this trial is testing

Acthar SLE (Systemic Lupus Erythematosus)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Repository Corticotropin Injection
NYU Langone Health
Post-approval studies (Phase 4)Study completedNCT01753401
What this trial is testing

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Mallinckrodt 38
Not applicableStudy completedNCT01904812
What this trial is testing

Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus
Centre Hospitalier Universitaire Dijon 356
Not applicableNot Yet RecruitingNCT06610422
What this trial is testing

Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
Lupus Nephritis
Assiut University 159
Very early researchNot Yet RecruitingNCT07266337
What this trial is testing

CD19/BCMA CAR-T for SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00001212
What this trial is testing

Drug Therapy in Lupus Nephropathy

Who this might be right for
Nephrotic SyndromeSystemic Lupus Erythematosus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45
Early research (Phase 1)Active Not RecruitingNCT06335979
What this trial is testing

An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).

Who this might be right for
Systemic Lupus Erythematosus, SLE
Novartis Pharmaceuticals 54
Not applicableStudy completedNCT03031925
What this trial is testing

Detection of Annexin A2 in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis
Centre Hospitalier Universitaire, Amiens 120
Not applicableNot Yet RecruitingNCT07209540
What this trial is testing

European LUpuS Inception-Cohort Developing initiATivE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
University of Aarhus 700
Testing effectiveness (Phase 2)Looking for participantsNCT06839976
What this trial is testing

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Who this might be right for
SLESystemic Lupus Erythematosus (SLE)CAR T Cell+4 more
Children's Hospital of Philadelphia 24
Next Page